Korean J Urol.  2006 Sep;47(9):978-981. 10.4111/kju.2006.47.9.978.

Evaluation of a Rapid Test for Detection of Chlamydia Trachomatis Infection in Female Commercial Sex Workers

• Lee G
• Shim JH
• Byun Y
• Kim H

• KMID: 2294095
• DOI: http://doi.org/10.4111/kju.2006.47.9.978

Abstract

Purpose
The importance of laboratory screening tests for female commercial sex workers (FCSWs) has been well documented to reduce the prevalence of chlamydial complications. A rapid test has been one of the standard chlamydial tests performed in Korean health centers. Although the process of the rapid test is simple, the sensitivity is inconsistent. Therefore, we evaluated the efficacy of QuickVue chlamydial detection kits, which is one of the rapid tests, by comparing this assay to an in-house polymerase chain reaction (PCR) method.
Materials and Methods
A total of 410 endo-cervical samples were consecutively collected in one health center. A rapid test was performed by using a QuickVue kit. Genomic DNA was extracted from cotton swabs. The cryptic plasmid of C. trachomatis from the genomic DNA was amplified by the PCR method.
Results
The overall sensitivity, specificity, positive predictive value and negative predictive value of the rapid test were 21%, 99%, 89% and 83%, respectively, based on the PCR results. Study of the serial dilutions of reference inclusion forming units (IFU) showed that the rapid test only detected chlamydial infections that had high counts of IFUs.
Conclusions
The rapid test is not good enough to detect chlamydial infection in FCSWs. Instead, a gene amplification test should be used for detecting chlamydial infections in FCSWs.

Keyword

Chlamydia trachomatis; Point-of-care systems; Sex; Workers

MeSH Terms

Chlamydia trachomatis*
Chlamydia*
DNA
Female*
Genes, vif
Humans
Mass Screening
Plasmids
Point-of-Care Systems
Polymerase Chain Reaction
Prevalence
Sensitivity and Specificity
Sex Workers*
DNA

Figure

• 

  Fig. 1 Serial dilution study for determining the sensitivity of the rapid test show a positive band in the test line (short arrow) in the one-time diluted test drops. All three samples show positive bands in the control lines (long arrow). The positive controls are from formalin-inactivated Chlamydia and the negative control is from heat-activated group B Streptococcus.

• 

  Fig. 2 The polymerase chain reaction test shows a very strong band at serial dilutions of 10, 5, 1 and even 1µl of the 102d diluted template volume. 1µl of 103d dilution means 1µl of the original template is diluted to 1:1,000 and 1µl of the diluted template is added to the polymerase chain reaction mixture for amplification. Marker: 100bp DNA ladder marker (Promega, USA).

Reference

1. Groseclose SL, Zaidi AA, DeLisle SJ, Levine WC, St Louis ME. Estimated incidence and prevalence of genital Chlamydia trachomatis infections in the United States, 1996. Sex Transm Dis. 1999. 26:339–344.

2. Stamm WE. Holmes KK, Sparling PF, Mardh P, Lemon SM, Stamm WE, Piot P, editors. Chlamydia trachomatis infections of the adult. Sexually transmitted diseases. 1999. 3rd ed. New York: McGraw-Hill;407–422.

3. Clinical Effectiveness Group (Association of Genitourinary Medicine and the Medical Society for the Study of Venereal Diseases). National guideline for the management of Chlamydia trachomatis genital tract infection. Sex Transm Infect. 1999. 75:Suppl 1. S4–S8.

4. Swain GR, McDonald RA, Pfister JR, Gradus MS, Sedmak GV, Singh A. Decision analysis: point-of-care Chlamydia testing vs. laboratory-based methods. Clin Med Res. 2004. 2:29–35.

5. Rani R, Corbitt G, Killough R, Curless E. Is there any role for rapid tests for Chlamydia trachomatis? Int J STD AIDS. 2002. 13:22–24.

6. Widjaja S, Cohen S, Brady WE, O'reilly K, Susanto , Wibowo A, et al. Evaluation of a rapid assay for detection of Chlamydia trachomatis infections in outpatient clinics in South Kalimantan, Indonesia. J Clin Microbiol. 1999. 37:4183–4185.

7. Lee G, Sohng I. Cryptic plasmid amplification of Chlamydia trachomatis at a Korean Health Center for female commercial sex workers. Korean J Urol. 2006. 47:37–41.

8. Tay YK, Goh CL, Chan R, Ali K, Nadarajah M, Sng J. Evaluation of enzyme immunoassay for the detection of anogenital infections caused by Chlamydia trachomatis. Singapore Med J. 1995. 36:173–175.

9. Woolley PD, Pumphrey J. Application of 'Clearview Chlamydia' for the rapid detection of cervical chlamydial antigen. Int J STD AIDS. 1997. 8:257–258.

10. Lo YM. Lo YM, editor. Introduction to the polymerase chain reaction. Clinical applications of PCR. 1998. Totowa: Humana Press Inc;3–10.

11. Mahony JB, Luinstra KE, Sellors JW, Chernesky MA. Comparison of plasmid- and chromosome-based polymerase chain reaction assays for detecting Chlamydia trachomatis nucleic acids. J Clin Microbiol. 1993. 31:1753–1758.

12. Kim BR, Lee GH. A semi-nested polymerase chain reaction for amplification of Chlamydia trachomatis omp1 gene. Korean J Urol. 2003. 44:812–818.

13. Eckert LO, Suchland RJ, Hawes SE, Stamm WE. Quantitative Chlamydia trachomatis cultures: correlation of chlamydial inclusion-forming units with serovar, age, sex, and race. J Infect Dis. 2000. 182:540–544.

14. Lyons JM, Morre SA, Airo-Brown LP, Pena AS, Ito JI. Acquired homotypic and heterotypic immunity against oculogenital Chlamydia trachomatis serovars following female genital tract infection in mice. BMC Infect Dis. 2005. 5:105.